What Is Function-Constrained Protein Design, and How Does It Make AI-Designed Proteins Actually Work?

 Figure 1. Function-constrained protein design: a generate–validate loop governed by function

[Category] C (Directed Evolution / Protein Engineering) | Cross-category D (AI / Algorithms / Platform)

Proteins for drugs, industrial enzymes, and biomaterials — nearly every biotechnology advance rests on a "designed protein." In the past, we relied on directed evolution to iterate through rounds of "trial and error" in the lab; today, AI can return thousands of candidate sequences in seconds. But there is a reality check: many AI-designed proteins fail to deliver the expected function in the test tube. The problem is precisely that the design objective is disconnected from "function."

Function-constrained protein design was created precisely to address this problem: it does not generate proteins randomly and then filter them afterward, but rather incorporates the 'target function' as a constraint in the generation and optimization process from the very beginning. This article will clearly explain what it is, how to enforce constraints within the model, which metrics should be measured, and how to effectively implement it through a dry and wet loop.

Background and Mechanism: Why Protein Design Must Look at Function

The success of a protein design depends not on whether the sequence "looks reasonable," but on whether it achieves the intended function in the experiment; function-constrained protein design makes "is function achieved?" a hard criterion in the pipeline.

· Structure design ≠ functional design: many classic designs use "does it fold, is the structure stable" as the success bar (structure design). For drugs, industrial enzymes, and biomaterials, that is only a prerequisite; what must actually be met are functional metrics such as binding affinity, catalytic rate, and specificity (functional design).

· Why structure alone is not enough: a correct structure does not guarantee a correct function. An enzyme active site, even correctly folded, also requires the right spatial orientation and protonation state of catalytic residues; a binder, even with a stable scaffold, needs complementarity of the interface shape, electrostatics, and hydrophobic balance. Functional constraints cover these "beyond-structure" hard metrics.

· Fitness landscape: the relationship between protein sequences and their functions can be regarded as a 'fitness landscape'—each sequence corresponds to a functional value, and design involves locating the 'peaks' on the landscape.

· Multiple constraints: a qualified functional protein must satisfy several objectives at once — high activity, good selectivity, thermal stability, solubility, easy expression, and good purification. No single metric means "usable."

· An analogy: when designing a key, "structure design" only guarantees it fits into the keyhole; "functional design" also requires it to turn the lock. Whether it turns the lock corresponds to the real functions — activity, affinity, and specificity.

· Prediction ≠ measurement: the sequence-structure-function mapping is complex, and there are discrepancies between model scoring and experimental measurements; therefore, 'function' must be used as a constraint throughout, rather than relying on a single computational simulation output.

Principles and Structure: How Functional Constraints Enter the Design Engine

The core mechanism of function-constrained protein design is to let the model "know" the target function while generating sequences — rather than generating first and filtering afterward — which sets the ceiling on design success rate.

· Protein language model + functional conditioning: functional labels (target, binding type, stability threshold) act as conditioning signals, so an autoregressive model generates sequences "tuned to the functional requirement."

· Structure generation + functional scoring: structure generators (inverse folding, backbone generation) produce candidates, then functional scoring functions (predicted binding, enzyme activity, stability) rank and truncate them.

· Knowledge-graph / functional-ontology constraints: confirmed functions, catalytic mechanisms, and interaction networks are mapped into the model embedding space and used as generation constraints.

· Hard vs. soft constraints: hard constraints must be satisfied (e.g., key catalytic residues must not mutate, interface residues must stay complementary), while soft constraints are optimization targets (e.g., "as soluble and thermostable as possible"). Their combination defines the search-space size.

· Sampling and solving strategy: exploring within constraints commonly uses Bayesian optimization, evolutionary search, or constrained generative sampling, balancing "satisfying constraints" with "pushing performance."

· Multi-objective trade-offs: activity and stability often pull against each other, so algorithms seek Pareto-optimal solutions within the constraint boundary rather than a "single-metric champion," especially for industrial enzymes that need both high activity and durability.

Figure 2. From sequence, to structure, to fitness landscape: functional constraints tie the design engine together

Assays and Selection: Which Metrics Prove "Function Achieved"

Function-constrained design must close the loop by measuring; different applications correspond to different functional metrics, and choosing the wrong assay system distorts the entire design loop.

· Binding class: affinity (KD / IC50), specificity and off-target risk.

· Catalytic class: kcat, Km, kcat/Km, enantioselectivity / substrate scope.

· Stability class: thermal denaturation temperature Tm, storage stability, tolerance to solvents / pH.

· Developability class: solubility, aggregate fraction, expression yield, purification recovery.

· Virtual screen → experimental validation: coarse-screen with scoring models, then precisely validate with high-content and high-throughput experiments to cut wasted assays.

· Deep mutational scanning (DMS): measure function across single and multiple mutations in bulk to directly "map" the local fitness landscape and provide high-value training data.

· Selection guidance: choose the metric set by target (drug/enzyme/material) and constraints (what to measure, how much, how fast); therapeutic proteins prioritize binding + developability, industrial enzymes prioritize activity + stability.

Conditions and Process: Key Points for a Dry–Wet Closed Loop

The real bottleneck of function-constrained design is not "computing" but "closing the loop" — whether computation and wet-lab validation can cycle efficiently and with low noise determines whether you finally get a qualified protein.

· Dry–wet loop, four steps: in-silico design → express & purify → assay function → retrain model → feed data back to step one.

· Active-learning / batch strategy: choose which candidates to test each round (covering diversity and high-confidence predictions) to maximize information gain while controlling total screening volume.

· Expression and purification system: host (E. coli / yeast / mammalian cells), tags, and purification flow affect assay quality and must be standardized in advance.

· Data standardization: standardize assay conditions and control batches to suppress technical noise; otherwise the model gets "led astray."

· Value the negatives: keeping only successful data weakens model discrimination; "failed" assay results are equally valuable training signals.

· Stopping criteria and cost: define "stop when target metric is reached" or "stop after N rounds" to avoid endless spend; also estimate the time and cost per round against the return.

· Scalability: growing from dozens to thousands of candidates requires automated liquid handling, high-throughput detection, and unified data management; otherwise throughput plateaus and the loop loses meaning.

· Reuse and transfer: the same platform, models, and data migrate to different targets or substrates, amortizing marginal design and assay cost and accelerating later projects. 

Figure 3. Dry–wet closed loop: from in-silico design, through wet-lab validation, and back to the model

With MatwingsVenus® (protein agent): Turning Function Constraints into an Executable Loop

The value of MatwingsVenus® (晓鹜®) is turning "function-constrained design" from an academic concept into a reusable dry–wet closed-loop platform, where algorithms, experiments, and experts collaborate on a single data map.

· MatwingsVenus® (晓鹜®) dry–wet closed-loop platform: connects functional-constraint modeling, sequence generation, virtual screening, wet-lab validation, and model retraining into a reusable production line.

· Wet-lab services: handle expression, purification, and functional assays, producing standardized data that flows back to refine the model.

· Expert center: provide domain judgment on metric selection, assay design, and process scale-up, avoiding "the algorithm knows, the experiment is blind."

· CTA: for selection advice on function-constrained design, sample submission, or a quote, call 13061973951 or email info@matwings.com.

Related products / services

· [Wet-lab services](https://matvenus.com/zh/products/wet-lab)

· [Expert center](https://matvenus.com/zh/products/expert-center)

· [Dry–wet closed-loop platform](https://matvenus.com/zh/dry-wet-closed-loop-platform)

FAQ

How is function-constrained protein design different from traditional directed evolution?

Function-constrained design starts from the target function and directly generates new sequences, exploring sequence space beyond natural proteins; traditional directed evolution must start from an existing protein and "climb" slowly with libraries and screening, limited by evolutionary history. The two are often complementary — computational design gives a starting point, directed evolution refines it.

What is the main bottleneck in function-constrained design today?

The main bottleneck is the still-low experimental success rate (industry reports that the success rate for de novo designed functional proteins is often below 20%), plus multi-objective trade-offs, prediction–measurement gaps, and the throughput and cost of wet-lab work. Data quality and loop efficiency decide success or failure.

What practical problems does function-constrained protein design solve?

It applies to optimizing affinity and specificity of antibodies/binders, engineering heat- and solvent-tolerant industrial enzymes, high-solubility therapeutic proteins, and synthetic-biology parts that need specific catalytic or regulatory functions.

What role does the dry–wet closed loop play in function-constrained design?

The dry–wet loop feeds each round of wet-lab data back to the model, making predictions increasingly accurate and compensating for the error of a single in-silico prediction; it is the reliable guarantee that "designed" also means "workable."

Summary

The criterion for function-constrained protein design is not "does the sequence look good" but "does the measured function meet the target." It treats function as a constraint and couples computation with experiment into a loop, a key path to moving AI protein design from "can compute" to "can use." For deployment, first clarify the target function and assay system, then let algorithms and experiments iterate together — which is often the most efficient route.

[One-Sentence Conclusion] Function-constrained protein design makes "function achieved" the design target and closes the loop between computation and experiment, so AI-designed proteins actually work.

Explore MatwingsVenus® (protein agent)

To learn more about function-constrained protein design and dry–wet closed-loop solutions, contact MatwingsVenus® (晓鹜®): call 86-13061973951 or email info@matwings.com.

More news

· [To be verified: additional links on function-constrained protein design / MatwingsVenus® (晓鹜®) platform news]